{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:20:43Z","timestamp":1793834443221,"version":"4.6.1"},"reference-count":265,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"AstraZeneca UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.mucimm.2025.03.003","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T06:34:04Z","timestamp":1743143644000},"page":"524-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Airway epithelial cells as drivers of severe asthma pathogenesis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-0258","authenticated-orcid":false,"given":"Del","family":"Dorscheid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6187-2385","authenticated-orcid":false,"given":"Gail M.","family":"Gauvreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2361-422X","authenticated-orcid":false,"given":"Steve N.","family":"Georas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-5982","authenticated-orcid":false,"given":"Pieter S.","family":"Hiemstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Varricchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart N.","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9849-4701","authenticated-orcid":false,"given":"Gianni","family":"Marone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2025.03.003_b0005","unstructured":"Global Initative for Asthma. Global strategy for asthma management and prevention. 2023. Available from: https:\/\/ginasthma.org\/2023-gina-main-report\/. Accessed 10 April 2024."},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0010","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2222.2011.03917.x","article-title":"Lung damage and airway remodelling in severe asthma","volume":"42","author":"Brightling","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/cea.13378","article-title":"Severe asthma\u2014a population study perspective","volume":"49","author":"Backman","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.mucimm.2025.03.003_b0025","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/JAA.S327659","article-title":"Severe asthma in a general population study: prevalence and clinical characteristics","author":"R\u00f6nnebjerg","year":"2021","journal-title":"J Asthma Allergy"},{"issue":"12","key":"10.1016\/j.mucimm.2025.03.003_b0030","first-page":"2075","article-title":"Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment","volume":"34","author":"Chen","year":"2018","journal-title":"CMRO"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/resp.13730","article-title":"Rational oral corticosteroid use in adult severe asthma: a narrative review","volume":"25","author":"Chung","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.mucimm.2025.03.003_b0040","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0045","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1183\/09031936.00165106","article-title":"Severe exacerbations predict excess lung function decline in asthma","volume":"30","author":"Bai","year":"2007","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.mucimm.2025.03.003_b0050","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1111\/all.15473","article-title":"Biologics and airway remodeling in severe asthma","volume":"77","author":"Varricchi","year":"2022","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0055","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b0060","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.202110-2265OC","article-title":"Mucus plugs persist in asthma, and changes in mucus plugs associate with changes in airflow over time","volume":"205","author":"Tang","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mucimm.2025.03.003_b0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-042220-015902","article-title":"The pathology of asthma: what is obstructing our view?","volume":"18","author":"Aegerter","year":"2023","journal-title":"Annu Rev Pathol."},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0075","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1164\/rccm.201504-0763PP","article-title":"Evolving concepts of asthma","volume":"192","author":"Gauthier","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0080","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0090","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2013present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/imcb.12522","article-title":"The onset, development and pathogenesis of severe neutrophilic asthma","volume":"100","author":"Zhang","year":"2022","journal-title":"Immunol Cell Biol"},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b0110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma IL6 levels, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaci.2019.08.031","article-title":"Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma","volume":"145","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0120","article-title":"Distinct spatial and temporal roles for Th1, Th2, and Th17 cells in asthma","volume":"13","author":"Luo","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.mucimm.2025.03.003_b0125","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.4049\/jimmunol.2200288","article-title":"Mechanisms of corticosteroid resistance in type 17 asthma","volume":"209","author":"Hong","year":"2022","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b0130","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/all.12445","article-title":"Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma","volume":"69","author":"Kupczyk","year":"2014","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0135","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jaip.2023.02.020","article-title":"Clinical implications of longitudinal blood eosinophil counts in patients with severe asthma","volume":"11","author":"Bleecker","year":"2023","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0140","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/thx.2009.126722","article-title":"Effects of steroid therapy on inflammatory cell subtypes in asthma","volume":"65","author":"Cowan","year":"2010","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0145","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2737","article-title":"The airway epithelium in asthma","volume":"18","author":"Lambrecht","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0155","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","article-title":"Regulation of immune responses by the airway epithelial cell landscape","volume":"21","author":"Hewitt","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0160","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1183\/09031936.00141514","article-title":"The innate immune function of airway epithelial cells in inflammatory lung disease","volume":"45","author":"Hiemstra","year":"2015","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0165","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41385-020-00370-7","article-title":"Cellular and functional heterogeneity of the airway epithelium","volume":"14","author":"Davis","year":"2021","journal-title":"Mucosal Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.mucimm.2025.03.003_b0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2222.1999.00016.x","article-title":"The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma","volume":"29","author":"Holgate","year":"1999","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/cells8040342","article-title":"Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies?","volume":"8","author":"Ito","year":"2019","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.mucimm.2025.03.003_b0180","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0185","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00260-2020","article-title":"Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics","volume":"56","author":"Porsbjerg","year":"2020","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b0190","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.cell.2021.04.019","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.mucimm.2025.03.003_b0195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/JAA.S324080","article-title":"The role of defective epithelial barriers in allergic lung disease and asthma development","volume":"15","author":"Noureddine","year":"2022","journal-title":"J Asthma Allergy"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b0200","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/cells11091387","article-title":"Role of respiratory epithelial cells in allergic diseases","volume":"11","author":"Jakwerth","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.mucimm.2025.03.003_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2019.05.001","article-title":"The airway epithelium in asthma","volume":"142","author":"Bonser","year":"2019","journal-title":"Adv Immunol"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0210","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jaci.2020.04.010","article-title":"Epithelial barriers in allergy and asthma","volume":"145","author":"Hellings","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/01902148.2015.1040528","article-title":"Urban particulate matter increases human airway epithelial cell IL-1\u03b2 secretion following scratch wounding and H1N1 influenza A exposure in vitro","volume":"41","author":"Hirota","year":"2015","journal-title":"Exp Lung Res"},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b0220","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","article-title":"A cellular census of human lungs identifies novel cell states in health and in asthma","volume":"25","author":"Vieira Braga","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12964-021-00740-z","article-title":"Long-term differentiating primary human airway epithelial cell cultures: how far are we?","volume":"19","author":"Bukowy-Bieryllo","year":"2021","journal-title":"Cell Commun Signal"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0230","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaci.2010.05.046","article-title":"Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma","volume":"126","author":"Thomas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chest.2017.11.008","article-title":"Mucins, mucus, and goblet cells","volume":"154","author":"Ma","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.mucimm.2025.03.003_b0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-407697-6.00004-0","article-title":"Cellular and molecular biology of airway mucins","volume":"303","author":"Lillehoj","year":"2013","journal-title":"Int Rev Cell Mol Biol."},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0245","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1183\/13993003.00120-2015","article-title":"Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions","volume":"48","author":"Janssen","year":"2016","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/mi.2008.5","article-title":"Mucins in the mucosal barrier to infection","volume":"1","author":"Linden","year":"2008","journal-title":"Mucosal Immunol"},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b0255","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/all.15279","article-title":"Differentiation of bronchial epithelial spheroids in the presence of IL\u201013 recapitulates characteristic features of asthmatic airway epithelia","volume":"77","author":"Pat","year":"2022","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.mucimm.2025.03.003_b0260","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1365-2222.2011.03852.x","article-title":"IL\u201013\u2010induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells","volume":"41","author":"Kanoh","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0265","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1378\/chest.101.4.916","article-title":"Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack","volume":"101","author":"Aikawa","year":"1992","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.mucimm.2025.03.003_b0270","doi-asserted-by":"crossref","first-page":"e181024","DOI":"10.1172\/jci.insight.181024","article-title":"Peroxidase-mediated mucin cross-linking drives pathologic mucus gel formation in IL-13\u2013stimulated airway epithelial cells","volume":"9","author":"Liegeois","year":"2024","journal-title":"JCI Insight"},{"issue":"2 Suppl","key":"10.1016\/j.mucimm.2025.03.003_b0275","doi-asserted-by":"crossref","first-page":"AB368","DOI":"10.1016\/j.jaci.2023.11.879","article-title":"Evaluating the effect of dupilumab on type 2 airway inflammation and mucus plugging in patients with uncontrolled moderate-to-severe asthma: the VESTIGE Trial","volume":"153","author":"Castro","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0280","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00204-2019","article-title":"Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma","volume":"6","author":"Castro","year":"2020","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0285","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1183\/09031936.00089214","article-title":"Club cells, CC10 and self-control at the epithelial surface","volume":"44","author":"Hiemstra","year":"2014","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0290","first-page":"26","article-title":"The role and importance of club cells (Clara cells) in the pathogenesis of some respiratory diseases","volume":"13","author":"Rokicki","year":"2016","journal-title":"Kardiochir Torakochirurgia Pol."},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0295","doi-asserted-by":"crossref","first-page":"L652","DOI":"10.1152\/ajplung.00192.2022","article-title":"An update in club cell biology and its potential relevance to chronic obstructive pulmonary disease","volume":"324","author":"Blackburn","year":"2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0300","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.stem.2020.03.009","article-title":"The cellular and physiological basis for lung repair and regeneration: past, present, and future","volume":"26","author":"Basil","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0305","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1165\/rcmb.2018-0199OC","article-title":"The club cell marker SCGB1A1 downstream of FOXA2 is reduced in asthma","volume":"60","author":"Zhu","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0310","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3390\/diagnostics13040808","article-title":"Airway epithelium: a neglected but crucial cell type in asthma pathobiology","volume":"13","author":"Singh","year":"2023","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.mucimm.2025.03.003_b0315","doi-asserted-by":"crossref","DOI":"10.15252\/embj.20105114","article-title":"SARS\u2010CoV\u20102 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0320","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1159\/000530374","article-title":"Impact of changes in human airway epithelial cellular composition and differentiation on SARS-CoV-2 infection biology","volume":"15","author":"Thaler","year":"2023","journal-title":"J Innate Immun"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0325","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/alr.22142","article-title":"Solitary chemosensory cells producing interleukin-25 and group-2 innate lymphoid cells are enriched in chronic rhinosinusitis with nasal polyps","volume":"8","author":"Patel","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"43","key":"10.1016\/j.mucimm.2025.03.003_b0330","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax7224","article-title":"Airway brush cells generate cysteinyl leukotrienes through the ATP sensor P2Y2","volume":"5","author":"Ualiyeva","year":"2020","journal-title":"Sci Immunol"},{"issue":"66","key":"10.1016\/j.mucimm.2025.03.003_b0335","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj0474","article-title":"Tuft cell\u2013produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation","volume":"6","author":"Ualiyeva","year":"2021","journal-title":"Sci Immunol"},{"issue":"28","key":"10.1016\/j.mucimm.2025.03.003_b0340","doi-asserted-by":"crossref","first-page":"eaat9453","DOI":"10.1126\/sciimmunol.aat9453","article-title":"The cysteinyl leukotriene 3 receptor regulates expansion of IL-25\u2013producing airway brush cells leading to type 2 inflammation","volume":"3","author":"Bankova","year":"2018","journal-title":"Sci Immunol"},{"issue":"7718","key":"10.1016\/j.mucimm.2025.03.003_b0345","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41586-018-0393-7","article-title":"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes","volume":"560","author":"Montoro","year":"2018","journal-title":"Nature"},{"issue":"7718","key":"10.1016\/j.mucimm.2025.03.003_b0350","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-018-0394-6","article-title":"A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte","volume":"560","author":"Plasschaert","year":"2018","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.mucimm.2025.03.003_b0355","doi-asserted-by":"crossref","first-page":"14789","DOI":"10.3390\/ijms241914789","article-title":"Transcriptional regulation of airway epithelial cell differentiation: insights into the notch pathway and beyond","volume":"24","author":"Cumplido-Laso","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7718","key":"10.1016\/j.mucimm.2025.03.003_b0360","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41586-018-0393-7","article-title":"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes","volume":"560","author":"Montoro","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107872","article-title":"Single-cell and population transcriptomics reveal pan-epithelial remodeling in type 2-high asthma","volume":"32","author":"Jackson","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.mucimm.2025.03.003_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.988573","article-title":"Single-cell RNA-sequencing in asthma research","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"issue":"8013","key":"10.1016\/j.mucimm.2025.03.003_b0375","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41586-024-07377-1","article-title":"Airway hillocks are injury-resistant reservoirs of unique plastic stem cells","volume":"629","author":"Lin","year":"2024","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0380","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s004289900177","article-title":"Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans","volume":"436","author":"Fujimura","year":"2000","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0385","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1165\/rcmb.2023-0292LE","article-title":"Single-cell transcriptomes, lineage, and differentiation of functional airway microfold cells","volume":"69","author":"Surve","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0390","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/s41467-024-46469-4","article-title":"Single-cell division tracing and transcriptomics reveal cell types and differentiation paths in the regenerating lung","volume":"15","author":"Martins","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0395","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41467-020-15647-5","article-title":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis","volume":"11","author":"Tsukui","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0400","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2014.05.049","article-title":"Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation","volume":"134","author":"Georas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0405","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-physiol-012110-142150","article-title":"Tight junction pore and leak pathways: a dynamic duo","volume":"73","author":"Shen","year":"2011","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0410","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbamem.2007.07.012","article-title":"Adherens and tight junctions: structure, function and connections to the actin cytoskeleton","volume":"1778","author":"Hartsock","year":"2008","journal-title":"Biochim Biophys Acta."},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0415","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/all.14421","article-title":"Epithelial cell dysfunction, a major driver of asthma development","volume":"75","author":"Heijink","year":"2020","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.mucimm.2025.03.003_b0420","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","article-title":"Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?","volume":"21","author":"Akdis","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0425","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1165\/rcmb.2013-0541RT","article-title":"Breaking barriers: new insights into airway epithelial barrier function in health and disease","volume":"50","author":"Rezaee","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6691","key":"10.1016\/j.mucimm.2025.03.003_b0430","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.adk2758","article-title":"Bronchoconstriction damages airway epithelia by crowding-induced excess cell extrusion","volume":"384","author":"Bagley","year":"2024","journal-title":"Science"},{"issue":"163","key":"10.1016\/j.mucimm.2025.03.003_b0435","doi-asserted-by":"crossref","first-page":"210112","DOI":"10.1183\/16000617.0112-2021","article-title":"Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD","volume":"31","author":"Aghapour","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0440","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jaci.2011.08.035","article-title":"Polyinosinic: polycytidylic acid induces protein kinase D\u2013dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells","volume":"128","author":"Rezaee","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0445","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/cea.14425","article-title":"Role of epithelial barrier function in inducing type 2 immunity following early-life viral infection","volume":"54","author":"Tian","year":"2024","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0450","doi-asserted-by":"crossref","DOI":"10.4161\/tisb.24333","article-title":"Interleukin-4 and interleukin-13 cause barrier dysfunction in human airway epithelial cells","volume":"1","author":"Saatian","year":"2013","journal-title":"Tissue Barriers"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0455","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jaci.2012.05.052","article-title":"Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-\u03b3 and IL-4","volume":"130","author":"Soyka","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b0460","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1091\/mbc.e02-03-0134","article-title":"Regulation of airway tight junctions by proinflammatory cytokines","volume":"13","author":"Coyne","year":"2002","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0465","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1165\/rcmb.2011-0031OC","article-title":"Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to respiratory syncytial virus and air pollution","volume":"45","author":"Hackett","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"10.1016\/j.mucimm.2025.03.003_b0470","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1593\/neo.121088","article-title":"E-cadherin controls bronchiolar progenitor cells and onset of preneoplastic lesions in mice","volume":"14","author":"Ceteci","year":"2012","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0475","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1038\/s41598-018-31500-8","article-title":"Characterization of a lung epithelium specific E-cadherin knock-out model: implications for obstructive lung pathology","volume":"8","author":"Post","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0480","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.it.2011.03.004","article-title":"E-cadherin: gatekeeper of airway mucosa and allergic sensitization","volume":"32","author":"Nawijn","year":"2011","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0485","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1165\/rcmb.2006-0160OC","article-title":"Der p, IL-4, and TGF-beta cooperatively induce EGFR-dependent TARC expression in airway epithelium","volume":"36","author":"Heijink","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"10.1016\/j.mucimm.2025.03.003_b0490","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.4049\/jimmunol.178.12.7678","article-title":"Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity","volume":"178","author":"Heijink","year":"2007","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b0495","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0500","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","article-title":"The cytokines of asthma","volume":"50","author":"Lambrecht","year":"2019","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0505","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1165\/ajrcmb.24.4.4360","article-title":"Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts","volume":"24","author":"Berin","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0510","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12950-024-00427-5","article-title":"Progress of CCL20-CCR6 in the airways: a promising new therapeutic target","volume":"21","author":"Li","year":"2024","journal-title":"J Inflamm (Lond)"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0515","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0520","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1165\/rcmb.2004-0196OC","article-title":"Primary human alveolar type II epithelial cell CCL20 (macrophage inflammatory protein-3alpha)-induced dendritic cell migration","volume":"32","author":"Thorley","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b0525","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI119341","article-title":"Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids","volume":"99","author":"Lilly","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0530","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-stimulated genes: what do they all do?","volume":"6","author":"Schoggins","year":"2019","journal-title":"Annu Rev Virol"},{"issue":"140","key":"10.1016\/j.mucimm.2025.03.003_b0535","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1183\/16000617.0101-2015","article-title":"Bronchial epithelium in children: a key player in asthma","volume":"25","author":"Carsin","year":"2016","journal-title":"Eur Respir Rev"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0540","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0091-6749(98)70008-9","article-title":"Epithelial cells as regulators of airway inflammation","volume":"102","author":"Polito","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0545","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.20112691","article-title":"Interleukin-1\u03b1 controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33","volume":"209","author":"Willart","year":"2012","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0550","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1073\/pnas.0607305104","article-title":"Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NF\u03baB","volume":"104","author":"Lee","year":"2007","journal-title":"Proc Natl Acad Sci"},{"issue":"Suppl 3","key":"10.1016\/j.mucimm.2025.03.003_b0555","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1164\/ajrccm.162.supplement_3.15tac2","article-title":"Antigen presentation in the lung","volume":"162","author":"Holt","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0560","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI124606","article-title":"Epithelial cell-derived cytokines: more than just signaling the alarm","volume":"129","author":"Roan","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mucimm.2025.03.003_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975914","article-title":"Epithelial cell alarmin cytokines: frontline mediators of the asthma inflammatory response","volume":"13","author":"Duchesne","year":"2022","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.mucimm.2025.03.003_b0570","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A large-scale, consortium-based genomewide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0575","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1038\/s41467-021-26347-z","article-title":"Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region","volume":"12","author":"Aneas","year":"2021","journal-title":"Nat Comms"},{"key":"10.1016\/j.mucimm.2025.03.003_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2022.101727","article-title":"TSLP and IL25 variants are related to asthma and atopy","volume":"30","author":"de Lima","year":"2023","journal-title":"Gene Reports"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0585","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/all.15666","article-title":"Decoding the genetic and epigenetic basis of asthma","volume":"78","author":"Stikker","year":"2023","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0590","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1165\/rcmb.2009-0418OC","article-title":"Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma","volume":"44","author":"Harada","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0595","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.chest.2016.10.042","article-title":"Epithelial-derived cytokines in asthma","volume":"151","author":"Mitchell","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0600","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/all.15609","article-title":"Sounding the alarmins\u2014The role of alarmin cytokines in asthma","volume":"78","author":"Gauvreau","year":"2023","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0605","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/01902148.2018.1536175","article-title":"TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast","volume":"44","author":"Cao","year":"2018","journal-title":"Exp Lung Res"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0610","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/02770903.2014.921196","article-title":"IL-33 promotes airway remodeling and is a marker of asthma disease severity","volume":"51","author":"Guo","year":"2014","journal-title":"J Asthma"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b0615","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/1535370219843827","article-title":"IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts","volume":"244","author":"Xu","year":"2019","journal-title":"Exp Biol Med"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0620","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/srep02301","article-title":"Thymic stromal lymphopoietin induces migration in human airway smooth muscle cells","volume":"3","author":"Redhu","year":"2013","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0625","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells","volume":"183","author":"Pr\u00e9fontaine","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0630","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3389\/fimmu.2018.01595","article-title":"Thymic stromal lymphopoietin isoforms, inflammatory disorders, and cancer","volume":"9","author":"Varricchi","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0635","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","article-title":"Role of thymic stromal lymphopoietin in allergy and beyond","volume":"23","author":"Ebina-Shibuya","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0640","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2024.02.020","article-title":"TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD","volume":"124","author":"Can\u00e8","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.mucimm.2025.03.003_b0645","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/bloodadvances.2016002352","article-title":"IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells","volume":"1","author":"Camelo","year":"2017","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0650","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1378\/chest.11-1782","article-title":"Mast cell-airway smooth muscle crosstalk: the role of thymic stromal lymphopoietin","volume":"142","author":"Kaur","year":"2012","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0655","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/all.12435","article-title":"Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin\u2010mediated induction of Th2 and Th9 responses","volume":"69","author":"Froidure","year":"2014","journal-title":"Allergy"},{"issue":"521","key":"10.1016\/j.mucimm.2025.03.003_b0660","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam8858","article-title":"TSLP signaling in CD4+ T cells programs a pathogenic T helper 2 cell state","volume":"11","author":"Rochman","year":"2018","journal-title":"Sci Signal"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0665","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jaci.2015.04.011","article-title":"Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin","volume":"136","author":"Fornasa","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0670","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/cells10082012","article-title":"Human lung-resident macrophages express and are targets of thymic stromal lymphopoietin in the tumor microenvironment","volume":"10","author":"Braile","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.mucimm.2025.03.003_b0675","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41590-019-0524-9","article-title":"TSLP: from allergy to cancer","volume":"20","author":"Corren","year":"2019","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b0680","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3390\/ijms25074049","article-title":"Thymic stromal lymphopoietin (TSLP) is cleaved by human mast cell tryptase and chymase","volume":"25","author":"Can\u00e8","year":"2024","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.mucimm.2025.03.003_b0685","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejim.2023.07.026","article-title":"Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis","volume":"117","author":"Marcella","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0690","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","article-title":"Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma","volume":"24","author":"Gauvreau","year":"2020","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0695","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2023.11.915","article-title":"Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation","volume":"153","author":"Andreasson","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b0700","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.4049\/jimmunol.1701455","article-title":"Elevated expression of IL-33 and TSLP in the airways of human asthmatics in vivo: a potential biomarker of severe refractory disease","volume":"200","author":"Li","year":"2018","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.mucimm.2025.03.003_b0705","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","article-title":"Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity","volume":"174","author":"Ying","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0710","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaci.2011.08.031","article-title":"Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma","volume":"129","author":"Shikotra","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0715","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.imlet.2016.08.004","article-title":"Increased expression of thymic stromal lymphopoietin in induced sputum from asthmatic children","volume":"178","author":"Berra\u00efes","year":"2016","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0720","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1038\/s41598-021-86179-1","article-title":"Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma","volume":"11","author":"Ko","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0725","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin\u201033 (IL\u201033): a nuclear cytokine from the IL\u20101 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0730","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12552","article-title":"IL\u201033: biological properties, functions, and roles in airway disease","volume":"278","author":"Drake","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mucimm.2025.03.003_b0735","first-page":"A7799","article-title":"Pyroptosis is a novel mechanism of IL-33 release from airway epithelial cells. D54. Interplay of Diverse Cellular and Molecular Pathways in Asthma and Airway Disease","volume":"197","author":"Bernard","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b0740","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41590-022-01255-6","article-title":"Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion","volume":"23","author":"Chen","year":"2022","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0745","first-page":"e136166","article-title":"Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease","volume":"6","author":"Katz-Kiriakos","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.mucimm.2025.03.003_b0750","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3389\/fimmu.2018.02601","article-title":"The pleiotropic immunomodulatory functions of IL-33 and its implications in tumor immunity","volume":"9","author":"Afferni","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0755","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1056838","article-title":"Basophils from allergy to cancer","volume":"13","author":"Poto","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0760","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1038\/ncomms9327","article-title":"Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat Comms"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0765","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02210-2022","article-title":"Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE\/EGFR signalling complex","volume":"62","author":"Strickson","year":"2023","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0770","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","article-title":"Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33","volume":"19","author":"Cayrol","year":"2018","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0775","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/ijpvm.IJPVM_179_16","article-title":"Comparison of interleukin-33 serum levels in asthmatic patients with a control group and relation with the severity of the disease","volume":"8","author":"Momen","year":"2017","journal-title":"Int J Prev Med"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0780","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000488015","article-title":"IL-33 and its receptor ST2 after inhaled allergen challenge in allergic asthmatics","volume":"176","author":"Mitchell","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0785","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/rccm.201712-2468LE","article-title":"Expression of IL-33 and TSLP and their receptors in asthmatic airways after inhaled allergen challenge","volume":"198","author":"Al-Sajee","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mucimm.2025.03.003_b0790","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12931-018-0872-2","article-title":"Serum sST2 levels predict severe exacerbation of asthma","volume":"19","author":"Watanabe","year":"2018","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0795","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1165\/rcmb.2012-0304OC","article-title":"Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells","volume":"49","author":"Kouzaki","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"256","key":"10.1016\/j.mucimm.2025.03.003_b0800","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009124","article-title":"Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation","volume":"6","author":"Beale","year":"2014","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0805","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000355331","article-title":"IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma","volume":"163","author":"Tang","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0810","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5114\/ada.2017.71428","article-title":"Sputum interleukin-25 correlates with asthma severity: a preliminary study","volume":"35","author":"Papli\u0144ska-Goryca","year":"2018","journal-title":"Postepy Dermatol Alergol."},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0815","doi-asserted-by":"crossref","first-page":"1900563","DOI":"10.1183\/13993003.00563-2019","article-title":"Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD","volume":"55","author":"Osei","year":"2020","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0820","doi-asserted-by":"crossref","first-page":"e20231236","DOI":"10.1084\/jem.20231236","article-title":"TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation","volume":"221","author":"Schmitt","year":"2024","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0825","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaci.2014.09.015","article-title":"Thymic stromal lymphopoietin signaling in CD4+ T cells is required for TH2 memory","volume":"135","author":"Wang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0830","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.637948","article-title":"Modulating Th2 cell immunity for the treatment of asthma","volume":"12","author":"Le\u00f3n","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b0835","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b0840","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.4049\/jimmunol.181.7.4780","article-title":"IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101333","article-title":"Immunologic mechanisms in asthma","volume":"46","author":"Boonpiyathad","year":"2019","journal-title":"Semin Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0850","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3389\/fimmu.2019.02918","article-title":"T follicular helper cell subsets and the associated cytokine IL-21 in the pathogenesis and therapy of asthma","volume":"10","author":"Gong","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0855","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/all.12878","article-title":"T follicular helper (Tfh) cells in normal immune responses and in allergic disorders","volume":"71","author":"Varricchi","year":"2016","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0860","first-page":"963","article-title":"High frequency of circulating follicular helper T cells in patients with bronchial asthma","volume":"60","author":"Gong","year":"2014","journal-title":"Clin Lab"},{"issue":"10","key":"10.1016\/j.mucimm.2025.03.003_b0865","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ni.3244","article-title":"Innate immunological function of TH2 cells in vivo","volume":"16","author":"Guo","year":"2015","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0870","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1hi cells are multipotential \u2018inflammatory\u2019type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0875","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaci.2019.01.027","article-title":"Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients","volume":"144","author":"Winkler","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0880","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/resp.14506","article-title":"Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics","volume":"28","author":"Malik","year":"2023","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0885","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2017.03.032","article-title":"Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin","volume":"141","author":"Liu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0890","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MCP.0000000000000647","article-title":"The different faces of the macrophage in asthma","volume":"26","author":"van der Veen","year":"2020","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0895","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1465-9921-15-72","article-title":"Impaired macrophage phagocytosis of bacteria in severe asthma","volume":"15","author":"Liang","year":"2014","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0900","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jaci.2008.03.008","article-title":"Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma","volume":"121","author":"Fitzpatrick","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0905","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2008.07.007","article-title":"Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages","volume":"122","author":"Goleva","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0910","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0091-6749(91)90149-I","article-title":"Increased secretion of tumor necrosis factor \u03b1 and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction","volume":"88","author":"Gosset","year":"1991","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"10.1016\/j.mucimm.2025.03.003_b0915","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.3390\/ijms21217930","article-title":"Dendritic cells: critical regulators of allergic asthma","volume":"21","author":"Morianos","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0920","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nm.1946","article-title":"House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells","volume":"15","author":"Hammad","year":"2009","journal-title":"Nat Med"},{"issue":"6147","key":"10.1016\/j.mucimm.2025.03.003_b0925","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1240342","article-title":"Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4","volume":"341","author":"Millien","year":"2013","journal-title":"Science"},{"issue":"6252","key":"10.1016\/j.mucimm.2025.03.003_b0930","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.aac6623","article-title":"Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells","volume":"349","author":"Schuijs","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0935","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12016-018-8720-1","article-title":"Mast cell-mediated orchestration of the immune responses in human allergic asthma: current insights","volume":"56","author":"Elieh Ali Komi","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0940","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/cells10010145","article-title":"IL-33 and superantigenic activation of human lung mast cells induce the release of angiogenic and lymphangiogenic factors","volume":"10","author":"Cristinziano","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b0945","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2011.09.007","article-title":"The role of mast cells in allergic inflammation","volume":"106","author":"Amin","year":"2012","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.mucimm.2025.03.003_b0950","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1398-9995.2010.02372.x","article-title":"Angiogenesis and lymphangiogenesis in bronchial asthma","volume":"65","author":"Detoraki","year":"2010","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0955","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/mai.2001.111928","article-title":"Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis","volume":"107","author":"Hoshino","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b0960","doi-asserted-by":"crossref","first-page":"2101865","DOI":"10.1183\/13993003.01865-2021","article-title":"Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma","volume":"60","author":"Al-Shaikhly","year":"2022","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b0965","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jaci.2013.08.052","article-title":"Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33","volume":"133","author":"Lai","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b0970","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3389\/fimmu.2019.00821","article-title":"Mast cells and their progenitors in allergic asthma","volume":"10","author":"M\u00e9ndez-Enr\u00edquez","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b0975","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1164\/ajrccm.162.6.9912001","article-title":"Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma","volume":"162","author":"Amin","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0980","first-page":"507","article-title":"Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls","volume":"137","author":"Tripathi","year":"2013","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b0985","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1183\/09031936.00179713","article-title":"Protocadherin-1: epithelial barrier dysfunction in asthma and eczema","volume":"43","author":"Faura Tellez","year":"2014","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0990","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jaci.2014.03.037","article-title":"Epistasis between serine protease inhibitor Kazal-type 5 (SPINK5) and thymic stromal lymphopoietin (TSLP) genes contributes to childhood asthma","volume":"134","author":"Myers","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b0995","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2019.01.052","article-title":"Functional genomics of CDHR3 confirms its role in HRV-C infection and childhood asthma exacerbations","volume":"144","author":"Everman","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b1000","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4168\/aair.2019.11.5.604","article-title":"Genes and pathways regulating decline in lung function and airway remodeling in asthma","volume":"11","author":"Hur","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13148-021-01049-x","article-title":"A review of epigenetic changes in asthma: methylation and acetylation","volume":"13","author":"Sheikhpour","year":"2021","journal-title":"Clin Epigenetics"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b1010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1164\/rccm.201506-1243OC","article-title":"Genome-wide methylation study identifies an IL-13\u2013induced epigenetic signature in asthmatic airways","volume":"193","author":"Nicodemus-Johnson","year":"2016","journal-title":"Am J Respir Critical Care Med"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b1015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S2213-2600(18)30466-1","article-title":"DNA methylation in nasal epithelium, atopy, and atopic asthma in children: a genome-wide study","volume":"7","author":"Forno","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b1020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaci.2023.05.018","article-title":"Cis- and trans-eQTM analysis reveals novel epigenetic and transcriptomic immune markers of atopic asthma in airway epithelium","volume":"152","author":"Kim","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ajhg.2009.08.007","article-title":"Allele-specific chromatin remodeling in the ZPBP2\/GSDMB\/ORMDL3 locus associated with the risk of asthma and autoimmune disease","volume":"85","author":"Verlaan","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/hmg\/ddu479","article-title":"Risk of childhood asthma is associated with CpG-site polymorphisms, regional DNA methylation and mRNA levels at the GSDMB\/ORMDL3 locus","volume":"24","author":"Acevedo","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b1035","doi-asserted-by":"crossref","first-page":"e44213","DOI":"10.1371\/journal.pone.0044213","article-title":"DNA methylation profiles of airway epithelial cells and PBMCs from healthy, atopic and asthmatic children","volume":"7","author":"Stefanowicz","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaci.2016.03.050","article-title":"Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients","volume":"139","author":"Wawrzyniak","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b1045","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jaci.2019.04.027","article-title":"Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis","volume":"144","author":"Steelant","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/cea.12168","article-title":"Activity and expression of histone acetylases and deacetylases in inflammatory phenotypes of asthma","volume":"44","author":"Gunawardhana","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.mucimm.2025.03.003_b1055","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.962693","article-title":"Role of airway epithelial cell miRNAs in asthma","volume":"3","author":"Boateng","year":"2022","journal-title":"Front Allergy"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4168\/aair.2020.12.1.4","article-title":"MicroRNAs in asthma and respiratory infections: identifying common pathways","volume":"12","author":"Taka","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4049\/jimmunol.1701798","article-title":"Genome-wide posttranscriptional dysregulation by microRNAs in human asthma as revealed by Frac-seq","volume":"201","author":"Martinez-Nunez","year":"2018","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b1070","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/all.14646","article-title":"Spotlight on microRNAs in allergy and asthma","volume":"76","author":"Weidner","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.mucimm.2025.03.003_b1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jenvman.2024.123053","article-title":"Exosomal miR-129-2-3p promotes airway epithelial barrier disruption in PM(2.5)-aggravated asthma","volume":"370","author":"Wang","year":"2024","journal-title":"J Environ Manage"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b1080","doi-asserted-by":"crossref","first-page":"e139019","DOI":"10.1172\/jci.insight.139019","article-title":"Epithelial miR-141 regulates IL-13-induced airway mucus production","volume":"6","author":"Siddiqui","year":"2021","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.mucimm.2025.03.003_b1085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111659","article-title":"A microRNA network dysregulated in asthma controls IL-6 production in bronchial epithelial cells","volume":"9","author":"Martinez-Nunez","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b1090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/all.12551","article-title":"MicroRNA-19a enhances proliferation of bronchial epithelial cells by targeting TGFbetaR2 gene in severe asthma","volume":"70","author":"Haj-Salem","year":"2015","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b1095","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4331\/wjbc.v5.i4.437","article-title":"Identification of host miRNAs that may limit human rhinovirus replication","volume":"5","author":"Bondanese","year":"2014","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.mucimm.2025.03.003_b1100","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.12659\/MSM.912412","article-title":"MicroRNA-744 inhibits proliferation of bronchial epithelial cells by regulating Smad3 pathway via targeting transforming growth factor-beta1 (TGF-beta1) in severe asthma","volume":"25","author":"Huang","year":"2019","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1105","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01294-2021","article-title":"Identification of asthma-associated microRNAs in bronchial biopsies","volume":"59","author":"Roffel","year":"2022","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b1110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2500\/108854195778771435","article-title":"Inhaled corticosteroid treatment for asthma","volume":"16","author":"Laitinen","year":"1995","journal-title":"Allergy Proc"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1513\/pats.200402-006MS","article-title":"Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary disease","volume":"1","author":"Chanez","year":"2004","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b1120","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.intimp.2011.12.006","article-title":"Glucocorticoids enhance airway epithelial barrier integrity","volume":"12","author":"Sekiyama","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1125","doi-asserted-by":"crossref","first-page":"L52","DOI":"10.1152\/ajplung.00104.2004","article-title":"Effects of dexamethasone on Muc5ac mucin production by primary airway goblet cells","volume":"288","author":"Lu","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"10.1016\/j.mucimm.2025.03.003_b1130","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/cea.13015","article-title":"Corticosteroid and long\u2010acting \u00df\u2010agonist therapy reduces epithelial goblet cell metaplasia","volume":"47","author":"Lachowicz-Scroggins","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.mucimm.2025.03.003_b1135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2559.2002.01378.x","article-title":"Expression of respiratory mucins in fatal status asthmaticus and mild asthma","volume":"40","author":"Groneberg","year":"2002","journal-title":"Histopathology"},{"issue":"6 Suppl","key":"10.1016\/j.mucimm.2025.03.003_b1140","doi-asserted-by":"crossref","first-page":"278S","DOI":"10.1378\/chest.122.6_suppl.278S","article-title":"Corticosteroid-induced apoptosis of airway epithelium: a potential mechanism for chronic airway epithelial damage in asthma","volume":"122","author":"White","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b1145","doi-asserted-by":"crossref","first-page":"L393","DOI":"10.1152\/ajplung.00030.2003","article-title":"\u03b2-adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells","volume":"285","author":"Tse","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b1150","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.179.2.1080","article-title":"TLR3-and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells","volume":"179","author":"Kato","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.mucimm.2025.03.003_b1155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2015.03.015","article-title":"Production of interleukin (IL)-33 in the lungs during multiple antigen challenge-induced airway inflammation in mice, and its modulation by a glucocorticoid","volume":"757","author":"Nabe","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1160","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2013.04.012","article-title":"IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma","volume":"132","author":"Saglani","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b1165","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaci.2015.01.016","article-title":"Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33","volume":"136","author":"Castanhinha","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"55","key":"10.1016\/j.mucimm.2025.03.003_b1170","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd3489","article-title":"Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases","volume":"6","author":"van der Ploeg","year":"2021","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1175","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/ncomms3675","article-title":"Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation","volume":"4","author":"Kabata","year":"2013","journal-title":"Nat Comms"},{"issue":"9","key":"10.1016\/j.mucimm.2025.03.003_b1180","article-title":"Anti-IL5 therapies for asthma","volume":"9","author":"Farne","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1185","article-title":"Omalizumab for asthma in adults and children","author":"Normansell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.mucimm.2025.03.003_b1190","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1080\/02770903.2018.1520865","article-title":"Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials","volume":"56","author":"Zayed","year":"2019","journal-title":"J Asthma"},{"key":"10.1016\/j.mucimm.2025.03.003_b1195","doi-asserted-by":"crossref","DOI":"10.1177\/17534666231202749","article-title":"Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study","volume":"17","author":"Guilleminault","year":"2023","journal-title":"Ther Adv Respir Dis"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1200","doi-asserted-by":"crossref","first-page":"00444","DOI":"10.1183\/23120541.00444-2022","article-title":"Definitions of non-response and response to biological therapy for severe asthma: a systematic review","volume":"9","author":"Khaleva","year":"2023","journal-title":"ERJ Open Research"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1205","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2021.07.008","article-title":"Emerging targeted therapeutics underscore immunologic heterogeneity of asthma","volume":"148","author":"Tamari","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.mucimm.2025.03.003_b1225","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1235","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/all.15918","article-title":"Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma","volume":"79","author":"Sverrild","year":"2024","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.mucimm.2025.03.003_b1230","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300135","article-title":"Tezepelumab and mucus plugs in patients with moderate-to-severe asthma","volume":"2","author":"Nordenmark","year":"2023","journal-title":"NEJM Evid"},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1240","doi-asserted-by":"crossref","first-page":"2101296","DOI":"10.1183\/13993003.01296-2021","article-title":"The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)","volume":"59","author":"Sverrild","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mucimm.2025.03.003_b1300","unstructured":"European Medicines Agency. Tezspire: EPAR. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tezspire. Accessed 28 August 2024."},{"key":"10.1016\/j.mucimm.2025.03.003_b1305","unstructured":"US Food and Drug Administration. Tezspire (tezepelumab) approved in the US for severe asthma. Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-maintenance-treatment-severe-asthma. Accessed 28 August 2024."},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b1310","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaci.2019.08.039","article-title":"IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation","volume":"144","author":"Allinne","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.mucimm.2025.03.003_b1215","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S2213-2600(21)00537-3","article-title":"Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study","volume":"10","author":"Wechsler","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1260","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1315","doi-asserted-by":"crossref","first-page":"2202210","DOI":"10.1183\/13993003.02210-2022","article-title":"Oxidised IL-33 signals via RAGE\/EGFR to drive a COPD-associated phenotype","volume":"62","author":"Strickson","year":"2023","journal-title":"Eur Respir J."},{"issue":"1","key":"10.1016\/j.mucimm.2025.03.003_b1320","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1038\/s41598-023-36642-y","article-title":"Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE\/EGFR to reduce inflammation and epithelial dysfunction","volume":"13","author":"England","year":"2023","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.mucimm.2025.03.003_b1265","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Randomized, double-blind, placebo-controlled study of brodalumab, a human anti\u2013IL-17 receptor monoclonal antibody, in moderate to severe asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1270","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2017.1341367","article-title":"The barrier hypothesis and Oncostatin M: restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease","volume":"5","author":"Pothoven","year":"2017","journal-title":"Tissue Barriers"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1325","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2015.01.043","article-title":"Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease","volume":"136","author":"Pothoven","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"10.1016\/j.mucimm.2025.03.003_b1210","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.mucimm.2025.03.003_b1220","doi-asserted-by":"crossref","first-page":"2201193","DOI":"10.1183\/13993003.01193-2022","article-title":"Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma","volume":"61","author":"Gauvreau","year":"2023","journal-title":"Eur Respir J"},{"issue":"18","key":"10.1016\/j.mucimm.2025.03.003_b1245","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","article-title":"Efficacy and safety of itepekimab in patients with moderate-to-severe asthma","volume":"385","author":"Wechsler","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.mucimm.2025.03.003_b1250","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S2213-2600(21)00167-3","article-title":"Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial","volume":"9","author":"Rabe","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.mucimm.2025.03.003_b1255","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1164\/rccm.202210-1881OC","article-title":"IL-33 expression is lower in current smokers at both transcriptomic and protein levels","volume":"208","author":"Faiz","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.mucimm.2025.03.003_b1275","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jaci.2019.09.007","article-title":"Targeting histone deacetylases to restore epithelial barrier integrity: A new option for personalized medicine in patients with allergic airway disorders?","volume":"144","author":"Georas","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.mucimm.2025.03.003_b1280","doi-asserted-by":"crossref","first-page":"1901280","DOI":"10.1183\/13993003.01280-2019","article-title":"Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission","volume":"55","author":"Vermeulen","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mucimm.2025.03.003_b1285","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pharmthera.2019.05.002","article-title":"A review on the pathophysiology of asthma remission","volume":"201","author":"Carpaij","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"174","key":"10.1016\/j.mucimm.2025.03.003_b1290","doi-asserted-by":"crossref","first-page":"240221","DOI":"10.1183\/16000617.0221-2024","article-title":"The epithelial era of asthma research: knowledge gaps and future direction for patient care","volume":"33","author":"Brightling","year":"2024","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10.1016\/j.mucimm.2025.03.003_b1295","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jaci.2020.04.024","article-title":"Environmental factors in epithelial barrier dysfunction","volume":"145","author":"S\u00f6zener","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021925000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021925000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:32:56Z","timestamp":1777707176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021925000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":265,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1933021925000297"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2025.03.003","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Airway epithelial cells as drivers of severe asthma pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2025.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}